Age (years)/type of tx Type (number) of NMSC Time post-tx to switch to everolimus, months Original IS regimen Everolimus-based IS regimen Other intervention for NMSC Follow-up (months) Outcome for NMSC Fernández et al. 2006 [51 ] 70/kidney SCC (3) 89 CsA Everolimus None Mean 6.5 months Existing lesions improved No recurrence Fernández et al. 2006 [51 ] 69/kidney SCC (1), BCC (1) 65 Tacrolimus Everolimus Excision Mean 6.5 months No recurrence Fernández et al. 2006 [51 ] 64/kidney SCC (6) 116 CsA MMF Everolimus MMF None Mean 6.5 months Existing lesions resolved No recurrence Fernández et al. 2006 [51 ] 70/kidney SCC (17), BCC (1) 206 Tacrolimus Everolimus Excision Mean 6.5 months No recurrence Fernández et al. 2006 [51 ] 67/kidney SCC (1), BCC (2) 130 CsA MMF Everolimus MMF None Mean 6.5 months Existing lesions resolved No recurrence Fernández et al. 2006 [51 ] 69/kidney SCC (2), BCC (1) & actinic keratosis (1) 178 CsA Everolimus Excision Mean 6.5 months No recurrence Pascual et al. 2006 [66 ] 64/kidney Recurrent cutaneous neoplasms (5) Not stated CsA MMF Steroids Everolimus MMF Steroids Excision 9 No recurrence Alter et al. 2014 [67 ] 71/kidney SCC (4), BD (2) 36 CsA MMF Steroids Everolimus MMF Steroids Excision, curettage, and photodynamic therapy 24 months SCC (2) Alter et al. 2014 [67 ] 49/heart BCC (2), BD (1) 180 CsA AZA Steroids Everolimus CsA Excision, curettage, and photodynamic therapy 24 months BCC (2) Alter et al. 2014 [67 ] 44/lung SCC (3), BD (3) 264 CsA AZA Steroids Everolimus CsA Steroids Excision, curettage, and photodynamic therapy 24 months No lesions (12 months) Alter et al. 2014 [67 ] 62/kidney SCC (1), BCC (1), BD (4) 66 AZA Steroids Everolimus Steroids Excision, curettage, and photodynamic therapy 24 months No lesions Alter et al. 2014 [67 ] 57/heart BD (2) 120 CsA AZA Steroids Everolimus CsA Steroids Excision, curettage, and photodynamic therapy 24 months No lesions